B

Biodyne Co Ltd
KOSDAQ:314930

Watchlist Manager
Biodyne Co Ltd
KOSDAQ:314930
Watchlist
Price: 16 470 KRW -6.79% Market Closed
Market Cap: 485.5B KRW
Have any thoughts about
Biodyne Co Ltd?
Write Note

Biodyne Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biodyne Co Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
B
Biodyne Co Ltd
KOSDAQ:314930
Capital Expenditures
-â‚©669.7m
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Dentium Co Ltd
KRX:145720
Capital Expenditures
-â‚©30.2B
CAGR 3-Years
-1%
CAGR 5-Years
22%
CAGR 10-Years
N/A
I
I Sens Inc
KOSDAQ:099190
Capital Expenditures
-â‚©25.6B
CAGR 3-Years
-29%
CAGR 5-Years
-24%
CAGR 10-Years
2%
J
Jeisys Medical Inc
KOSDAQ:287410
Capital Expenditures
-â‚©20.1B
CAGR 3-Years
-147%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Capital Expenditures
-â‚©8.5B
CAGR 3-Years
22%
CAGR 5-Years
15%
CAGR 10-Years
N/A
L
Lutronic Corp
KOSDAQ:085370
Capital Expenditures
-â‚©4.9B
CAGR 3-Years
16%
CAGR 5-Years
16%
CAGR 10-Years
11%
No Stocks Found

Biodyne Co Ltd
Glance View

Market Cap
485.5B KRW
Industry
Health Care

Biodyne Co., Ltd. engages in the development of cancer diagnosis solutions. The company is headquartered in Seoul, Seoul and currently employs 26 full-time employees. The company went IPO on 2021-03-17. The firm produces and sells LBC diagnostic equipment and diagnostic reagent kits. The firm's LBC equipment include PATHPLORER AUTO, PATHPLORER 4.7, PATHPLORER 4.63 and PATHPLORER ECO. The firm sells its products in domestic and overseas markets such as Japan, Russia, Portugal and Thailand.

Intrinsic Value
489.78 KRW
Overvaluation 97%
Intrinsic Value
Price
B

See Also

What is Biodyne Co Ltd's Capital Expenditures?
Capital Expenditures
-669.7m KRW

Based on the financial report for Dec 31, 2023, Biodyne Co Ltd's Capital Expenditures amounts to -669.7m KRW.

What is Biodyne Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
3%

Over the last year, the Capital Expenditures growth was 57%. The average annual Capital Expenditures growth rates for Biodyne Co Ltd have been 6% over the past three years , 3% over the past five years .

Back to Top